Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 25 entries
View as:

Pharmacokinetic, Safety and Efficacy Study of OMS201 in Subjects Undergoing Retrograde Ureteroscopic Removal of Upper Urinary Tract Stones

Phase: N/A Priority: Normal
NCT ID: NCT00857090 Org: User:
Start: 03/31/09 End: 12/31/10 Due: 12/31/11

Safety, Tolerability, and Pharmacokinetics of OMS643762 in Psychiatrically Stable Schizophrenia Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01952132 Org: User:
Start: 09/30/13 End: 04/30/14 Due: 04/30/15

Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT03608033 Org: User:
Start: 02/16/18 End: 10/18/23 Due: 10/18/24

Intraoperative Floppy Iris Syndrome Undergoing Intraocular Lens Replacement Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02093689 Org: User:
Start: 02/28/14 End: 08/31/14 Due: 08/31/15

Safety and Efficacy Study of OMS721 in Patients With Atypical Hemolytic Uremic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03205995 Org: User:
Start: 02/23/17 End: 02/29/20 Due: 02/28/21

Exploratory Study of OMS302 Injection in Subjects Undergoing Unilateral Cataract Extraction by Phacoemulsification.

Phase: N/A Priority: Normal
NCT ID: NCT00721695 Org: User:
Start: 05/31/08 End: 02/28/09 Due: 02/28/10

Safety and Efficacy Study of OMS906 in Patients With C3G and ICGN

Phase: N/A Priority: Normal
NCT ID: NCT06209736 Org: User:
Start: 03/01/24 End: 04/30/26 Due: 04/30/27

Double-Blind, Multicenter, Study Comparing the Efficacy and Safety of OMS103HP With Vehicle Irrigation Solution in Subjects Undergoing Meniscectomy

Phase: N/A Priority: Normal
NCT ID: NCT00624845 Org: User:
Start: 12/31/07 End: 05/31/09 Due: 05/31/10

Single Patient Expanded Access Treatment Plan For The Investigational Product Narsoplimab

Phase: N/A Priority: Normal
NCT ID: NCT04247906 Org: User:
Start: - End: - Due: -

Safety of OMS103HP in Patients Undergoing Anterior Cruciate Ligament (ACL) Reconstruction

Phase: N/A Priority: Normal
NCT ID: NCT00245271 Org: User:
Start: 10/31/04 End: 03/31/11 Due: 03/31/12

A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement

Phase: N/A Priority: Normal
NCT ID: NCT02132312 Org: User:
Start: 07/31/14 End: 09/12/16 Due: 09/12/17

Efficacy and Safety of OMS103HP in Patients Undergoing Autograft Anterior Cruciate Ligament (ACL) Reconstruction

Phase: N/A Priority: Normal
NCT ID: NCT00226772 Org: User:
Start: 06/30/05 End: 03/31/11 Due: 03/31/12

Long-Term Safety, Tolerability and Efficacy of OMS906 in Paroxysmal Nocturnal Hemoglobinuria

Phase: N/A Priority: Normal
NCT ID: NCT06298955 Org: User:
Start: 02/19/24 End: 04/30/27 Due: 04/30/28

Safety and Efficacy of OMS103HP-S Administered in Joint Irrigation Solution to Subjects Undergoing Arthroscopic Meniscectomy

Phase: N/A Priority: Normal
NCT ID: NCT01406561 Org: User:
Start: 08/31/11 End: 12/31/12 Due: 12/31/13

Safety and Efficacy of OMS643762 in Subjects With Huntington's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02074410 Org: User:
Start: 01/31/14 End: 10/15/14 Due: 10/15/15

Pharmacokinetic and Safety Study of OMS201 in Subjects Undergoing Ureteroscopic Treatment for Removal of Urinary Tract-Located Stones

Phase: N/A Priority: Normal
NCT ID: NCT00599664 Org: User:
Start: 12/31/07 End: 09/30/08 Due: 09/30/09

Efficacy and Safety of OMS103HP in Patients Undergoing Allograft Anterior Cruciate Ligament (ACL) Reconstruction

Phase: N/A Priority: Normal
NCT ID: NCT00226759 Org: User:
Start: 11/30/04 End: 03/31/11 Due: 03/31/12

Safety and Efficacy of OMS906 in Paroxysmal Nocturnal Hemoglobinuria Patients With a Sub-optimal Response to Ravulizumab

Phase: N/A Priority: Normal
NCT ID: NCT05972967 Org: User:
Start: 03/27/23 End: 07/31/25 Due: 07/31/26

Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721

Phase: N/A Priority: Normal
NCT ID: NCT02682407 Org: User:
Start: 02/29/16 End: 12/31/20 Due: 12/31/21

Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies

Phase: N/A Priority: Normal
NCT ID: NCT02222545 Org: User:
Start: 11/02/14 End: 08/11/20 Due: 08/11/21

Study of the Safety and Efficacy of OMS906 in Patients With Paroxysmal Nocturnal Hemoglobinuria

Phase: N/A Priority: Normal
NCT ID: NCT05889299 Org: User:
Start: 12/09/22 End: 06/30/24 Due: 06/30/25

Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA

Phase: N/A Priority: Normal
NCT ID: NCT05855083 Org: User:
Start: 05/01/23 End: 12/31/25 Due: 12/31/26

Safety, Efficacy and Pharmacokinetics of OMS302 in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification

Phase: N/A Priority: Normal
NCT ID: NCT01579565 Org: User:
Start: 04/30/12 End: 01/31/13 Due: 01/31/14

Safety and Efficacy of OMS302 in Subjects Undergoing Unilateral Cataract Extraction With Lens Replacement (CELR)

Phase: N/A Priority: Normal
NCT ID: NCT01193127 Org: User:
Start: 07/31/10 End: 02/28/11 Due: 02/28/12

Safety and Efficacy of OMS302 in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification

Phase: N/A Priority: Normal
NCT ID: NCT01454063 Org: User:
Start: 09/30/11 End: 03/31/12 Due: 03/31/13